Patrick Keenan is the Managing Director of Prevail Partners, LLC, a life sciences investment firm focused on innovative clinical stage therapeutic, medical device and diagnostics companies. During his nine-year tenure, Prevail Partners has invested in over 30 private and public companies. These portfolio companies have entered into licensing deals with over $2 billion in payments and completed several successful IPOs. Patrick was previously in private law practice with a focus on intellectual property and was recognized as among Pennsylvania Super Lawyers™. He has been a speaker at several healthcare conferences, including Stem Cell Summit 2016 and 2018, Bio Korea 2013, and others. Patrick is a board member of Shimojani Inc. and the non-profit Peace of Mind Project. He obtained his undergraduate degree from Stockton University and Juris Doctorate from Rutgers School of Law.